SCHEMBL1090445

SCHEMBL1090445

COc1cccc(C(=O)N2CCC(N3CCCC(Nc4nccc(N5CCCCCC5)n4)C3)CC2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 4/20 0.50
▸ KDM4E B2RXH2 3/20 0.50
▸ GFER P55789 1/20 0.48
▸ HPGD P15428 1/20 0.47
▸ KMT2A Q03164 2/20 0.46
▸ LMNA P02545 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ CCNK O75909 2/20 0.45
▸ CDK12 Q9NYV4 2/20 0.45
▸ NOS3 P29474 1/20 0.45
▸ NOS1 P29475 1/20 0.45
▸ NOS2 P35228 1/20 0.45
▸ CCNC P24863 1/20 0.45
▸ CDK8 P49336 1/20 0.45
▸ MAPK10 P53779 2/20 0.44
▸ ABL1 P00519 1/20 0.44
▸ BCR P11274 1/20 0.44
▸ L3MBTL3 Q96JM7 2/20 0.44
▸ L3MBTL1 Q9Y468 2/20 0.44
▸ PDE2A O00408 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1090683 0.98 ALDH1A1 (0.48) ALDH1A1KDM4EGFERHPGDKMT2A
SCHEMBL1090288 0.96 ALDH1A1 (0.49) ALDH1A1KDM4EGFERHPGDKMT2A
SCHEMBL1090714 0.93 GFER (0.51) ALDH1A1GFERHPGDKMT2ACCNK
SCHEMBL1091454 0.92 GFER (0.51) ALDH1A1GFERHPGDKMT2ACCNK
SCHEMBL1090175 0.90 CDK12 (0.51) ALDH1A1KDM4ECCNKCDK12CCNC
SCHEMBL1091235 0.90 GFER (0.49) ALDH1A1GFERHPGDKMT2ATSHR
SCHEMBL1090616 0.90 GBA1 (0.48) HPGDKMT2ACCNKCDK12L3MBTL3
SCHEMBL1090286 0.89 CDK12 (0.49) KDM4ECCNKCDK12CCNCCDK8
SCHEMBL1090289 0.88 L3MBTL1 (0.51) ALDH1A1KDM4EKMT2ACCNKCDK12
SCHEMBL1090070 0.88 TDP1 (0.58) ALDH1A1KDM4ECCNKCDK12L3MBTL3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2012-06-21 — — US disclosed
US-8153625-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2012-04-10 — — US disclosed
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2010-09-02 — — US disclosed
US-7759336-B2 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2010-07-20 — — US disclosed
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof ONO PHARMACEUTICAL CO., LTD. (JP) 2007-07-19 — — US disclosed
EP-1571146-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF ONO PHARMACEUTICAL CO., LTD. (JP) 2005-09-07 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100221259-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 ALDH1A1 916/4885KDM4E 2001/4885GFER 1303/4885
US-20070167459-A1 Nitrogen-containing heterocyclic compounds and medicinal use thereof CXCR4, CXCL12, CXCR3 ALDH1A1 916/4885KDM4E 2001/4885GFER 1303/4885
US-20120156219-A1 NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS AND MEDICINAL USE THEREOF CXCR4, CXCL12, CXCR3 ALDH1A1 916/4885KDM4E 2001/4885GFER 1303/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback